Search database
Filter
3881
Text search: drug quality
Featured
Language
Document type
3069
343
260
82
38
35
29
11
9
3
2
Countries
272
111
109
102
99
96
90
85
81
81
81
75
67
67
66
58
55
46
45
41
41
38
35
32
32
30
29
28
27
23
21
17
16
16
15
15
15
11
11
10
9
9
9
9
8
7
7
7
7
6
6
6
6
5
5
5
4
4
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
331
310
210
156
100
98
83
55
52
37
32
30
29
26
26
25
24
24
23
22
22
21
20
20
20
20
18
18
18
17
17
16
16
15
15
14
14
13
13
13
12
12
12
12
12
11
11
10
10
10
10
10
10
9
9
9
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1668
289
141
140
69
55
41
1
1
Toolboxes
519
420
376
198
122
61
59
53
51
44
40
40
33
31
17
16
16
10
9
8
6
3
1
 Download
  View PDF
 Add to my MEDBOX

Improving the quality of health services: tools and resources

World Health Organization WHO (2019) C_WHO
This compendium collates current tools and resources on quality improvement developed by the WHO Service Delivery and Safety Department and provides examples of how the tools and resources have been applied in country settings. The target audience f ... more
 Download
  View PDF
 Add to my MEDBOX

Global overview of drug demand and supply - Latest trends, cross-cutting issues

United Nations Office on Drugs and Crime (2018) C2
World Drug Report 2018 -2-
 Download
  View PDF
 Add to my MEDBOX

Analysis of drug markets - Opiates, cocaine, cannabis, synthetic drugs

United Nations Office on Drugs and Crime (2018) C2
World Drug Report 2018 -3-
 Download
  View PDF
 Add to my MEDBOX

Women and drugs - Drug use, drug supply and their consequences

United Nations Office on Drugs and Crime (2018) C2
World Drug Report 2018 -5-
 Download
  View PDF
 Add to my MEDBOX

Management of drug withdrawal

World Health Organization (2012) C_WHO
Q2: What interventions are safe and effective for drug withdrawal (cannabis, amphetamines, cocaine, benzodiazepines, and inhalants)?
 Download
  View PDF
 Add to my MEDBOX

EU Drug Markets Report

European Monitoring Centre for Drugs and Drug Addiction (2016) C2
Strategic Overview
 Download
  View PDF
 Add to my MEDBOX

Quality of Care and Client Satisfaction with Maternal Health Services in Nepal

Acharya, S., S. Sharma, B. Dulal, K. Aryal DHS; USAID (2018) CC
This report presents further analysis of the 2015 Nepal Health Facility Survey. Data analysis is based on the Donabedian framework for assessing quality of care in health services, which divides the indicators into three groups: structure, process, ... more
 Download
  View PDF
 Add to my MEDBOX

Philippine National Drug Formulary - Essential Medicines List, Volume I (7th Edition)

The National Formulary Committee, National Drug Policy, DOH Philippines (2008) C1
 Download
  View PDF
 Add to my MEDBOX

No Time to Wait: Securing the future from drug-resistant infections

IACG Interagency Coordination Group on Antimicral Resistance (2019) C_WHO
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis. If no action is taken - warns the UN Ad hoc Interagency Coordin ... more
 Download
  View PDF
 Add to my MEDBOX

No Time to Wait: Securing the future from drug-resistant infections. Summary of recommendations and key messages

IACG Interagency Coordination Group on Antimicral Resistance (2019) C_WHO
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
 Download
  View PDF
 Add to my MEDBOX

Global report on early warning indicators of HIV drug resistance

M. R. Jordan; N.Dean; D. Maradiaga World Health Organization WHO (2016) C_WHO
Technical Report
 Download
  View PDF
 Add to my MEDBOX

World Drug Report 2019 Booklet 1 Executive summary / Policy implications

United Nations Office on Drug and Crime UNODOC (2022) C1
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its spe ... more
 Download
  View PDF
 Add to my MEDBOX

World Drug Report 2019 Booklet 5 Drugs and the environment

United Nations Office on Drug and Crime UNODC (2022) C2
The booklet starts with a general overview of how illicit drugs and the environment are linked within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability. It highlights direct and indirect linkages and gives examples of the significant local and i ... more
 Download
  View PDF
 Add to my MEDBOX

Assessment of a revolving drug fund for essential asthma medicines in Benin

Gildas Agodokpessi, Nadia Aït-Khaled, Martin Gninafon, Leon Tawo, Wilfried Bekou, Christophe Perrin, Karen Bissell, Nils Billo, Donald A Enarson, Chen-Yuan Chiang Journal of Pharmaceutical Policy and Practice (2015) C2
Agodokpessi et al. Journal of Pharmaceutical Policy and Practice (2015) 8:12DOI 10.1186/s40545-015-0033-7 Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated the operation of the RDF and assessed wh ... more
 External Link
 Add to my MEDBOX

The Oxford Statement on Medicine Quality and Public Health

Nuffield Dept. of Medicine Centre for Tropical Medicine and Global Health (2018) CC
In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and ... more
 External Link
 Add to my MEDBOX

Establishing a national laboratory quality system for HIV diagnosis and monitoring in resource-limited settings: Experience from Senegal

Mbengue M.A.S., Moussa S., Papa A. D. et. al. African Journal of Laboratory Medicine (2016) C2
Senegal has adopted the World Health Organization–Joint United Nations Programme on HIV/AIDS recommended 90-90-90 targets.5 The adoption of this strategy means that the country is expected, by 2020, to have 90% of its population living with HIV diagnosed, 90% of all those diagnosed receiving susta ... more
 Add to my MEDBOX

Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis

José A. Caminero International Union Against Tuberculosis and Lung Disease (The Union) (2013)
 Add to my MEDBOX

Building Local Coalitions for containing drug resistance: A guide

USAID, Strengthening Pharmaceutical Systems SPS (2011) C1
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES FOR DETECTING AND REPORTING ADVERSE DRUG OR VACCINE REACTIONS AND EVENTS IN ZAMBIA

Zambia Medicines Regulatory Authority (ZAMRA) (2006) C2
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
 Download
  View PDF
 Add to my MEDBOX

Roadmap to prevent and combat drug-resistant tuberculosis

World Health Organization Europe (2011) C_WHO
 External Link
 Add to my MEDBOX

Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and metaanalysis

C. C. Onyedum, I. Alobu, K. N. Ukwaja PLOS One; O. Neyrolles (Institut de Pharmacologie et de Biologoie Structurale) (2017) CC
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
 Download
  View PDF
 Add to my MEDBOX

Maintaining and improving quality of care within HIV clinical services - Technical Brief

World Health Organization (2019) C_WHO
HIV Treatment
 Download
  View PDF
 Add to my MEDBOX

HIV and TB in Practice for nurses: Drug-resistant TB

Lesley Odendal (2013) CC
HIV & AIDS Treatment in Practice No.202
 Download
  View PDF
 Add to my MEDBOX

Operational Guidelines on Quality Assurance in Public Health Facilities

Ministry of Health & Family Welfare Government of India Ministry of Health & Family Welfare Government of India (2013) C1
For the Assesor's Guide Vol 1 and 2 see: nrhm.gov.in/images/pdf/programmes/maternal-health/guidelines/Operational_Guidelines_for_Quality_Assurance_in_Public_Health_Facilities_and_checklists-3_books.zip
 Download
  View PDF
 Add to my MEDBOX

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India + Annexures

Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare (2012) C1
 Download
  View PDF
 Add to my MEDBOX

Community-Based Care for Drug-Resistant Tuberculosis: A Guide for Implementers

United States Agency for International Development (USAID) (2011)
This guide provides practical, step-by-step guidance on how to organize, implement, and monitor community-based care for DR TB. It is equally useful for program planning or supervision. The target audience for this guide is TB Program Managers, governments, policy makers, nongovernmental organizatio ... more
 Download
  View PDF
 Add to my MEDBOX

Zambia: Guidelines for the programmatic Management of Drug-Resistant Tuberculosis

National TBLeprosy Control Programme, Ministry of Health, Zambia (2013) C1
 Download
  View PDF
 Add to my MEDBOX

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India

Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Nirman Bhavan (2012) CC
Revised National Tuberculosis Control Programme
 Add to my MEDBOX

Report National Tuberculosis Drug Resistance Survey, 2006-2007

National Center for TB and Leprosy Control (CENAT) , Cambodia (2011) CC
 Download
  View PDF
 Add to my MEDBOX

Prevention of Drug Use and Treatment of Drug Use Disorders in Rural Settings
recommended

United Nations Office on Drug and Crime UNODC (2017) C1
 Download
  View PDF
 Add to my MEDBOX

National HIV Service Quality Improvement Tool Kit

Ministry of Health, Ethiopia (2018) C1
 Add to my MEDBOX

WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update
recommended

Dennis Falzon, Elizabeth Harausz, Ernesto Jaramillo et al. World Health Organization (WHO) (2016) C_WHO
 External Link
 Add to my MEDBOX

Improving Private Drug Sellers’ Practices for Managing Common Health Problems in Nepal

Kafle KK., Karkee SB., Shrestha N., et al. JNHRC (2013) C1
J Nepal Health Res Counc 2013 May;11(24):198-204
 Download
  View PDF
 Add to my MEDBOX

Access to and Quality of Menstrual Regulation and Postabortion Care in Bangladesh: Evdence from a Survey of Health Facilities, 2014

Altaf Hossain, Isaac Maddow-Zimet, Meghan Ingerick et al. Guttmacher Institute (2017) C1
 Add to my MEDBOX

List of Medicines for Rural Drug Vendor, Ethiopia (LMRDV)

Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA) (2011) C1
Fourth edition
 Download
  View PDF
 Add to my MEDBOX

National Strategy on HIV Drug Resistance Monitoring and Surveillance in Nepal 2014-2020
recommended

Government of Nepal Ministry of Health and Population Department of Health Services, National Centre for AIDS and STD Control (2014) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Integrated Biological and Behavioral Surveillance (IBBS) Survey among Female Injecting Drug Users in Kathmandu Valley, Round I, 2016

Ministry of Health Nepal; National Centre for AIDS and STD Control (NCASC) (2016) C1
 Download
  View PDF
 Add to my MEDBOX

India: Guidelines for Quality Assurance of smear microscopy for diagnosing tuberculosis

Government of India, Central Tuberculosis Division, Ministry of Health and Family Welfare (2005) C1
 Download
  View PDF
 Add to my MEDBOX

Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended

World Health Organization WHO (2017) C_WHO
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an ... more
 Download
  View PDF
 Add to my MEDBOX

Uganda: THE NATIONAL DRUG POLICY AND AUTHORITY (REGISTRATION) REGULATIONS, 2014

The Government of Uganda The Uganda Gazette (2014) C2
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
 Download
  View PDF
 Add to my MEDBOX

Management of drug-resistant tuberculosis

World Health Organization (2014) C_WHO
Training for staff working at DR-TB management centres. Training modules
 Download
  View PDF
 Add to my MEDBOX

Situational analysis of quality improvement in maternal and neonatal health care, Sierra Leone

United Nations Population Fund UNFPA (2018) CC
 Download
  View PDF
 Add to my MEDBOX

Strengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation

I. A. Vasilyeva Russian Ministry of Health (2017) C1
Accessed November 2017
 Download
  View PDF
 Add to my MEDBOX

Policy Implementation Package for new TB drug introduction (Russian version)

World Health Organization Europe Всемирная организация здравоохранения (2014) C_WHO
ПАКЕТ МЕР ПО РЕАЛИЗАЦИИ ПОЛИТИКИ В ОТНОШЕНИИ ВНЕДРЕНИЯ НОВЫХ ПРОТИВОТУБЕРКУЛЕЗНЫХ ПРЕПАРАТОВ
 Download
  View PDF
 Add to my MEDBOX

Anti-tuberculosis drug resistance among tuberculosis patients in Ukraine and risk factors for MDR-TB

World Health Organization Europe (2016) C_WHO
Results of the first national survey, 2013–2014
 Download
  View PDF
 Add to my MEDBOX

Public health dimension of the world drug problem

World Health Organization WHO (2022) C_WHO
Report by the Director-General. 75th World health assembly 25 April 2022
 Download
  View PDF
 Add to my MEDBOX

Expansion Plan of Programmatic Management of Drug Resistant TB (PMDT)

National TB Control Programme, Bangladesh World Health Organization WHO, Bangladesh (2013) C1
 Download
  View PDF
 Add to my MEDBOX

International Standards for the Treatment of Drug Use Disorders
recommended

World Health Organization, United Nations Office on Drugs and Crime (2017) C2
 Download
  View PDF
 Add to my MEDBOX

International Standards of Drug Use Prevention

World Health Organization (WHO); United Nations Office on Drug and Crime UNODC (2019) C_WHO
2nd revised edition. Accessed Apri. 17, 2019 Prevention strategies based on scientific evidence working with families, schools, and communities can ensure that children and youth, especially the most marginalized and poor, grow and stay healthy and safe into adulthood and old age. For every dollar ... more
 Download
  View PDF
 Add to my MEDBOX

Field Guide for the Management of Drug-Resistant Tuberculosis
recommended

A. Piubello The International Union Against Tuberculosis and Lung Disease (2018)
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the programmatic management of drug-resistant tuberculosis

World Health Organization (2011) C_WHO
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly’s resolution on prevention an ... more
 Download
  View PDF
 Add to my MEDBOX

DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended

Médecins sans Frontières (2016) C_WHO
4th edition. This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the treatment of drug-susceptible tuberculosis and patient care, 2017 up-date

H. Schünemann, S.T. Aung, F. Bonsu et al. World Health Organisation (WHO) (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

TIP 18: The Tuberculosis Epidemic: Legal and Ethical Issues for Alcohol and Other Drug Treatment Providers: Treatment Improvement Protocol (TIP) Series 18

D. H. Mulligan, U.S Department of health and human service (1995) C2
 Download
  View PDF
 Add to my MEDBOX

Global action plan on HIV drug resistance 2017–2021

World Health Organization (WHO) (2017) C_WHO
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ... more
 Download
  View PDF
 Add to my MEDBOX

Rencana aksi nasional: Programmatic Management of Drug Resistance Tuberculosis, Pengendalian Tuberkulosis Indonesia 2011-2014

Kementerian Kesehatan Republik Indonesia (2011) C1
National Action Plan: Programmatic Management of Drug Resistance Tuberculosis, Tuberculosis Control Indonesia
 Download
  View PDF
 Add to my MEDBOX

Preventing and responding to HIV drug resistance in the african region

World Health Organization WHO (Africa) World Health Organization WHO (Africa) (2019) C_WHO
Regional action plan 2019-2023
 Download
  View PDF
 Add to my MEDBOX

Uniting to Build HIV Prevention for Drug Users - The Georgian Harm Reduction Network

P. Case USAID; PEPFAR (U.S. President's Emergency Plan for AIDS Relief), AIDSTAR-One (2012) C2
AIDSTAR-One | CASE STUDY SERIES November 2012
 Download
  View PDF
 Add to my MEDBOX

Advocacy Guide: HIV/AIDS Prevention among injecting drug users

A. Ball; M. Beg; G. Weiler; et al. World Health Organization; UNAIDS; United Nations on Drugs and Crime (2004) C_WHO
 Download
  View PDF
 Add to my MEDBOX

The Public Health Dimension of the World Drug problem

World Health Organization WHO (2019) C_WHO
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
 Download
  View PDF
 Add to my MEDBOX

Approaches for mobile and migrant populations in the context of malaria multi-drug resistance and malaria elimination in the Greater Mekong Subregion

World Health Organization ( WHO), Regional Office for South-East-Asia (2016) C_WHO
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (‎GMS)‎ has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response, ... more
 Download
  View PDF
 Add to my MEDBOX

Good Pharmacy Practice - Joint FIP/WHO Guidelines on Good Pharmacy Practice: Standards for Quality of Pharmacy Services

World Health Organization (WHO), International Pharmaceutical Federation (FIP) (2011) C_WHO
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients they serve. The role of FIP is to provide leadership for na ... more
 Download
  View PDF
 Add to my MEDBOX

Framework for the engagement of all health care providers in the management of drug resistant tuberculosis

World Health Organization (2015) C_WHO
The END TB strategy
 Download
  View PDF
 Add to my MEDBOX

TB Guidelines for Nurses in the Care and Control of Tuberculosis and Multi-drug Resistant Tuberculosis

International Council of Nurses (2015) C2
3rd edition.
 Download
  View PDF
 Add to my MEDBOX

Algorithm for laboratory diagnosis and treatment-monitoring of pulmonary tuberculosis and drug-resistant tuberculosis using state-of-the-art rapid molecular diagnostic technologies

World Health Organization (2017) C_WHO
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
 Download
  View PDF
 Add to my MEDBOX

GUIDELINE ON SUBMISSION OF DOCUMENTATION FOR REGISTRATION OF A MULTISOURCE (GENERIC) FINISHED PHARMACEUTICAL PRODUCT (FPP): QUALITY PART IN THE COMMON TECHNICAL DOCUMENT (CTD) FORMAT

Medicines Control Authority of Zimbabwe (MCAZ) (2012) C2
 External Link
 Add to my MEDBOX

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

G. B. Migliori, E. Pontali, G. Sotgiu, et al. International Journal of Molecular Scienes (2017) C2
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
 Download
  View PDF
 Add to my MEDBOX

Strategic plan for the prevention and control of multidrug-resistant and extensively drug-resistant tuberculosis in the Eastern Mediterranean Region (2010–2015)

World Health Organization Eastern Mediterranean (2010) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Infection prevention, control and surveillance: Limiting the development and spread of drug-resistance

O’Neill, J. Review on Antimicrobial Resistance (2016) C1
 Download
  View PDF
 Add to my MEDBOX

National Guidelines and Operational Manual for Programmatic Management of Drug Resistant TB (PMDT), 2nd ed.

Government of the People’s Republic of Bangladesh, Directorate General of Health Services (2013) C1
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of ... more
 Download
  View PDF
 Add to my MEDBOX

Harsh punishment - The Human Toll of Georgia’s Abusive Drug Policies

G. Gogia Human Rights Watch (2018) C2
 Download
  View PDF
 Add to my MEDBOX

Role of sterile injection equipment and outreach programmes for injecting drug users

World Health Organization (2012) C_WHO
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach mode ... more
 Download
  View PDF
 Add to my MEDBOX

Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe

A. T. Makadzange; M. Higgins-Biddle; B. Chimukangara; et al. PLOS One (2015) CC
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
 External Link
 Add to my MEDBOX

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon

G. F. Tchouwa; , S. Eymard-Duvernay; A. Cournil; et al. Elsevier; E Clinical Medecine (Published by the Lancet) (2018) C2
EClinicalMedicine 1 (2018) 21–27 https://doi.org/10.1016/j.eclinm.2018.06.005 2589-5370/© 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). EClinicalMedicine: journal homepage: https://www.jo ... more
 Add to my MEDBOX

Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users: An Integrated Approach

World Health Organization, UNAIDS, United Nations Office on Drugs and Crime (2008)
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
 Download
  View PDF
 Add to my MEDBOX

Updated Guidelines for Prevention of Parent to Child Transmission (PPTCT) of HIV using Multi Drug Anti-retroviral Regimen in India

NACO (2013)
 Download
  View PDF
 Add to my MEDBOX

Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis

World Health Organization (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Good Practices in strengthening health systems for the prevention and care of Tuberculosis and drug-resistant Tuberculosis

World Health Organization, Europe (2016) C_WHO
 Download
  View PDF
 Add to my MEDBOX

WHO treatment guidelines for isoniazid-resistant tuberculosis: Supplement to the WHO treatment guidelines for drug-resistant tuberculosis
recommended

World Health Organization WHO (2018) C_WHO
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
 Download
  View PDF
 Add to my MEDBOX

Thematic segment: Mental Health and HIV/AIDS – Promoting human rights, an integrated and person-centered approach to improving art adherence, well-being and quality of life

UNAIDS; STRIVE (2018) C2
1-13 December 2018 | Geneva, Switzerland UNAIDS Programme Coordinating Board Issue date: 23 November 2018 UNAIDS/PCB (43)/18.32
 Add to my MEDBOX

Health Information System Strategic Plan 2008-2015 , accountability, efficiency, quality, equity

Ministry of Health, Cambodia (2008) CC
 Download
  View PDF
 Add to my MEDBOX

Technical Report: Size Estimation of Sex Workers, Men who have Sex with Men, and Drug Users in Liberia

Simon-Pierre TEGANG, Jemee K. TEGLI (2011) C1
 Download
  View PDF
 Add to my MEDBOX

Medicines Catalog August 2018

Global Drug Facility World Health Organization WHO, Stop TB (2018) C_WHO
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
 Download
  View PDF
 Add to my MEDBOX

Diagnostics Catalog August 2018

Global Drug Facility World Health Organization WHO, Stop TB (2018) C_WHO
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
 External Link
 Add to my MEDBOX

Best practice portal: standards and guidelines
recommended

European Monitoring Centre for Drugs and Drug Addiction (2019) CC
The Best practice portal is a resource for professionals, policymakers and researchers in the drugs field. We provide information on the available evidence on drug-related prevention, treatment and harm reduction, focusing on the European context. T ... more
 Download
  View PDF
 Add to my MEDBOX

How to take medicines safely

German Agency for Quality in Medicine (ÄZQ) (2011) C1
Patient information on safe medical treatment. Available in: Arabic, English, French, Russian, Spanish, Turkish, German. This is the English version. For other language versions visit: http://www.patienten-information.de/kurzinformationen/arzneimittel-und-impfungen/sichere-arzneimitteltherapie
 Download
  View PDF
 Add to my MEDBOX

Uganda: Guidelines on good manufacturing practice for medicinal products - Part 1

National Drug Authority (NDA), Uganda (2017) C2
 Download
  View PDF
 Add to my MEDBOX

Uganda: Annual Pharmacovigilance Report July 2015 – June 2016

National Drug Authority, Uganda (2016) C1
 Add to my MEDBOX

Maldives National Action Plan for Containment of Antimicrobial Resistance 2017-2022

Maldives Food and Drug Authority Ministry of Health (2017) C2
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati ... more
 Download
  View PDF
 Add to my MEDBOX

Registration Guidelines for Medical Devices Bangladesh 2015

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Instructions for Completing Suspected Adverse Event Reporting Form

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2014) C1
 Add to my MEDBOX

Survey of Adherence to Antiretroviral Medicine inEthiopia

Ethiopian Drug Administration and Control Authority (DACA); et al. USAID (2007) C1
 Add to my MEDBOX

Antimicrobials use, reistance and containment baseline survey (Ethiopia)

Drug Administration and Control Authority of Ethiopia , et al. (2009) C1
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug ... more
 Add to my MEDBOX

Formulary of Narcotic Drugs and Psychotropic Substances for Ethiopia

Drug Administration and Control Authority (DACA) of Ethiopia (2004) C1
 Download
  View PDF
 Add to my MEDBOX

The Wise List 2015

Stockholm Drug and Therapeutics Committee (2015) C_WHO
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
 Download
  View PDF
 Add to my MEDBOX

Ethiopia: Standard Treatment Guidelines for Health Center

Drug Administration and Control Authority of Ethiopia Contents (2014) C1
3rd edition
 Download
  View PDF
 Add to my MEDBOX

Uganda: Guidelines on good manufacturing practice for medicinal products - ANNEXES

National Drug Authority (NDA), Uganda (2017) C1
Doc. No.: INS/GDL/001-(Annexes)
 Download
  View PDF
 Add to my MEDBOX

Strategies to prevent diversion of opioid substitution treatment medications

European Monitoring Centre for Drugs and Drug Addiction (2016) C2
Perspectives on Drugs
 Download
  View PDF
 Add to my MEDBOX

Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products Bangladesh

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Bangladesh Multiple Indicator Cluster Survey 2012-2013, Progotir Pathey. Key Findings

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh; UNICEF (2014) C1